Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease-Reference-Cited by-同舟云学术

Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease

Published:2004-08 Issue:5 Volume:37 Page:411-418
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Howard Laurence M.¹,Miller Stephen D.¹

Affiliation:

1. Department of Microbiology–Immunology, Interdepartmental Immunobiology Center, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL-60611, USA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08916930410001716095

Reference134 articles.

1. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

2. Antibodies to Murine CD40 Protect Normal and Malignant B Cells from Induced Growth Arrest

3. CD40 and its ligand: Central players in B lymphocyte survival, growth, and differentiation

4. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling;Arthritis Research & Therapy;2017-08-09

2. Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases;Journal of Controlled Release;2015-06

3. Role of CD154 in cancer pathogenesis and immunotherapy;Cancer Treatment Reviews;2015-05

4. New frontiers for platelet CD154;Experimental Hematology & Oncology;2015-03-01

5. Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis;The Kaohsiung Journal of Medical Sciences;2014-05